Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1985 Feb;38(2):140–145. doi: 10.1136/jcp.38.2.140

Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.

A Larsson, B Astedt
PMCID: PMC499093  PMID: 3881480

Abstract

Immunoreactive plasminogen activators were studied in tissue sections using a peroxidase method and monospecific antibodies to tissue plasminogen activator produced by a melanoma. Tissue plasminogen activator reactivity was found in skin melanomas and in endothelial and smooth muscle cells of arteries and veins. Vessels of the umbilical cord showed higher reactivity than peripheral vessels. Only faint antiurokinase reactivity was found. By means of the fibrin slide technique, fibrinolytic activity could be shown in peripheral vessel walls but not in the umbilical cord, which suggests that immunoreactivity of tissue plasminogen activator bound to an inhibitor can also be demonstrated. This method may be a useful tool in further studies of tissue plasminogen activator in physiological as well as pathological processes.

Full text

PDF
140

Images in this article

142Image
on p.142
143Image
on p.143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTRUP T. Fibrinolysis in the organism. Blood. 1956 Sep;11(9):781–806. [PubMed] [Google Scholar]
  2. ASTRUP T., STERNDORFF I. An activator of plasminogen in normal urine. Proc Soc Exp Biol Med. 1952 Dec;81(3):675–678. doi: 10.3181/00379727-81-19983. [DOI] [PubMed] [Google Scholar]
  3. Astedt B., Barlow G., Holmberg L. Time-related release of various molecular forms of urokinase in tissue culture. Thromb Res. 1977 Aug;11(2):149–153. doi: 10.1016/0049-3848(77)90033-0. [DOI] [PubMed] [Google Scholar]
  4. Astedt B., Holmberg L. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature. 1976 Jun 17;261(5561):595–597. doi: 10.1038/261595a0. [DOI] [PubMed] [Google Scholar]
  5. Astedt B., Pandolfi M. On release and synthesis of fibrinolytic activators in human organ culture. Rev Eur Etud Clin Biol. 1972 Mar;17(3):261–267. [PubMed] [Google Scholar]
  6. Camiolo S. M., Markus G., Evers J. L., Hobika G. H., DePasquale J. L., Beckley S., Grimaldi J. P. Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity. Int J Cancer. 1981 Feb 15;27(2):191–198. doi: 10.1002/ijc.2910270211. [DOI] [PubMed] [Google Scholar]
  7. Holmberg L., Bladh B., Astedt B. Purification of urokinase by affinity chromatography. Biochim Biophys Acta. 1976 Aug 12;445(1):215–222. doi: 10.1016/0005-2744(76)90174-1. [DOI] [PubMed] [Google Scholar]
  8. Holmberg L., Kristoffersson A. C., Lecander I., Wallén P., Astedt B. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase. Scand J Clin Lab Invest. 1982 Jun;42(4):347–354. [PubMed] [Google Scholar]
  9. Holmberg L., Lecander I., Persson B., Astedt B. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta. 1978 Nov 15;544(1):128–137. doi: 10.1016/0304-4165(78)90216-7. [DOI] [PubMed] [Google Scholar]
  10. Levin E. G. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci U S A. 1983 Nov;80(22):6804–6808. doi: 10.1073/pnas.80.22.6804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levin E. G., Loskutoff D. J. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol. 1982 Sep;94(3):631–636. doi: 10.1083/jcb.94.3.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ljungnér H., Holmberg L., Kjeldgaard A., Nilsson I. M., Astedt B. Immunological characterisation of plasminogen activators in the human vessel wall. J Clin Pathol. 1983 Sep;36(9):1046–1049. doi: 10.1136/jcp.36.9.1046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Loskutoff D. J., Edgington T. E. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3903–3907. doi: 10.1073/pnas.74.9.3903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Loskutoff D. J., Edgington T. S. An inhibitor of plasminogen activator in rabbit endothelial cells. J Biol Chem. 1981 May 10;256(9):4142–4145. [PubMed] [Google Scholar]
  15. Naito S., Sueishi K., Hattori F., Tanaka K. Immunological analysis of plasminogen activators from cultured human cancer cells. Virchows Arch A Pathol Anat Histol. 1980;387(3):251–257. doi: 10.1007/BF00454828. [DOI] [PubMed] [Google Scholar]
  16. Nielsen L. S., Hansen J. G., Skriver L., Wilson E. L., Kaltoft K., Zeuthen J., Danø K. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry. 1982 Dec 7;21(25):6410–6415. doi: 10.1021/bi00268a014. [DOI] [PubMed] [Google Scholar]
  17. PLOUG J., KJELDGAARD N. O. Urokinase an activator of plasminogen from human urine. I. Isolation and properties. Biochim Biophys Acta. 1957 May;24(2):278–282. doi: 10.1016/0006-3002(57)90194-4. [DOI] [PubMed] [Google Scholar]
  18. Pandolfi M. Histochemistry and assay of plasminogen activator. Rev Eur Etud Clin Biol. 1972 Mar;17(3):254–260. [PubMed] [Google Scholar]
  19. Pandolfi M., Nilsson I. M., Robertson B., Isacson S. Fibrinolytic activity of human veins. Lancet. 1967 Jul 15;2(7507):127–128. doi: 10.1016/s0140-6736(67)92964-9. [DOI] [PubMed] [Google Scholar]
  20. Pandolfi M., Robertson B., Isacson S., Nilsson I. M. Fibrinolytic activity of human veins in arms and legs. Thromb Diath Haemorrh. 1968 Nov 15;20(1):247–256. [PubMed] [Google Scholar]
  21. Rijken D. C., Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem. 1981 Jul 10;256(13):7035–7041. [PubMed] [Google Scholar]
  22. Rijken D. C., Wijngaards G., Welbergen J. Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res. 1980 Jun 15;18(6):815–830. doi: 10.1016/0049-3848(80)90204-2. [DOI] [PubMed] [Google Scholar]
  23. Salo T., Liotta L. A., Keski-Oja J., Turpeenniemi-Hujanen T., Tryggvason K. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis. Int J Cancer. 1982 Nov 15;30(5):669–673. doi: 10.1002/ijc.2910300520. [DOI] [PubMed] [Google Scholar]
  24. Svanberg L., Linell F., Pandolfi M., Astedt B. Plasminogen activators in ovarian tumours. Acta Pathol Microbiol Scand A. 1975 Mar;83(2):193–198. doi: 10.1111/j.1699-0463.1975.tb01374.x. [DOI] [PubMed] [Google Scholar]
  25. TODD A. S. The histological localisation of fibrinolysin activator. J Pathol Bacteriol. 1959 Jul;78:281–283. doi: 10.1002/path.1700780131. [DOI] [PubMed] [Google Scholar]
  26. Tarin D., Hoyt B. J., Evans D. J. Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumours. Br J Cancer. 1982 Aug;46(2):266–278. doi: 10.1038/bjc.1982.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vetterlein D., Bell T. E., Young P. L., Roblin R. Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells. J Biol Chem. 1980 Apr 25;255(8):3665–3672. [PubMed] [Google Scholar]
  28. Wu M. C., Yunis A. A. Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma. Int J Biochem. 1979;10(12):1001–1006. doi: 10.1016/0020-711x(79)90080-6. [DOI] [PubMed] [Google Scholar]
  29. Wu M., Arimura G. K., Yunis A. A. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry. 1977 May 3;16(9):1908–1913. doi: 10.1021/bi00628a023. [DOI] [PubMed] [Google Scholar]
  30. Wun T. C., Ossowski L., Reich E. A proenzyme form of human urokinase. J Biol Chem. 1982 Jun 25;257(12):7262–7268. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES